In a new pilot study at the Royal National Orthopaedic Hospital in London, researchers will utilize stem cells to promote the healing of painful tendon injuries such as tennis elbow. Initial studies suggest that, upon transplantation, the stem cells release growth factors to the point of injury, which induce the growth of new tendon tissue while reducing scar tissue to recover movement and flexibility.
Currently, one in three people suffer from tennis elbow, with only limited success being found in anti-inflammatory drugs. As clinical trials progress, the unique properties of human stem cells present the opportunity for developing personalized treatments to help patients suffering from painful tendon injuries. And as per the New York Times, this procedure is just the leading edge of stem cell treatments that will become commonplace in the very near future.
We believe the best stem cells to use in these emerging regenerative treatments will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn more about banking your own valuable stem cells to insure your family’s future health, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.